Detalhe da pesquisa
1.
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
Clin Infect Dis
; 59(12): 1768-76, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25139963
2.
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
J Hepatol
; 61(4): 761-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24882048
3.
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Liver Int
; 30(7): 1049-58, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20492512
4.
Super-infection with genotype 4 hepatitis C virus in a patient treated for genotype 3 acute hepatitis C.
AIDS
; 26(5): 655-6, 2012 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22398573